Literature DB >> 25740945

TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.

Noa Simchoni1, Charlotte Cunningham-Rundles2.   

Abstract

B cells activated by nucleic acid-sensing TLR7 and TLR9 proliferate and secrete immune globulins. Memory B cells are presumably more responsive due to higher TLR expression levels, but selectivity and differential outcomes remain largely unknown. In this study, peripheral blood human B cells were stimulated by TLR7 or TLR9 ligands, with or without IFN-α, and compared with activators CD40L plus IL-21, to identify differentially responsive cell populations, defined phenotypically and by BCR characteristics. Whereas all activators induced differentiation and Ab secretion, TLR stimulation expanded IgM(+) memory and plasma cell lineage committed populations, and favored secretion of IgM, unlike CD40L/IL-21, which drove IgM and IgG more evenly. Patterns of proliferation similarly differed, with CD40L/IL-21 inducing proliferation of most memory and naive B cells, in contrast with TLRs that induced robust proliferation in a subset of these cells. On deep sequencing of the IgH locus, TLR-responsive B cells shared patterns of IgHV and IgHJ usage, clustering apart from CD40L/IL-21 and control conditions. TLR activators, but not CD40L/IL-21, similarly promoted increased sharing of CDR3 sequences. TLR-responsive B cells were characterized by more somatic hypermutation, shorter CDR3 segments, and less negative charges. TLR activation also induced long positively charged CDR3 segments, suggestive of autoreactive Abs. Testing this, we found culture supernatants from TLR-stimulated B cells to bind HEp-2 cells, whereas those from CD40L/IL-21-stimulated cells did not. Human B cells possess selective sensitivity to TLR stimulation, with distinctive phenotypic and genetic signatures.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740945      PMCID: PMC4369401          DOI: 10.4049/jimmunol.1402690

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS.

Authors:  Eltaf Alamyar; Patrice Duroux; Marie-Paule Lefranc; Véronique Giudicelli
Journal:  Methods Mol Biol       Date:  2012

2.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 3.  Generation, expansion, migration and activation of mouse B1 cells.

Authors:  S Fagarasan; N Watanabe; T Honjo
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

Review 4.  CpG DNA as a vaccine adjuvant.

Authors:  Christian Bode; Gan Zhao; Folkert Steinhagen; Takeshi Kinjo; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 5.  B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.

Authors:  Michele Dal-Bo; Ilaria Del Giudice; Riccardo Bomben; Daniela Capello; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Davide Rossi; Antonella Zucchetto; Gabriele Pozzato; Roberto Marasca; Dimitar G Efremov; Anna Guarini; Giovanni Del Poeta; Robin Foà; Gianluca Gaidano; Valter Gattei
Journal:  Br J Haematol       Date:  2011-02-08       Impact factor: 6.998

6.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

7.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

Authors:  Hendrik Poeck; Moritz Wagner; Julia Battiany; Simon Rothenfusser; Daniela Wellisch; Veit Hornung; Bernd Jahrsdorfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

Review 8.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

9.  IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.

Authors:  L Giordani; M Sanchez; I Libri; M G Quaranta; B Mattioli; M Viora
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

10.  A human equivalent of mouse B-1 cells?

Authors:  Marc Descatoire; Jean-Claude Weill; Claude-Agnès Reynaud; Sandra Weller
Journal:  J Exp Med       Date:  2011-12-19       Impact factor: 14.307

View more
  19 in total

1.  Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.

Authors:  Carole Le Coz; Bertram Bengsch; Caroline Khanna; Melissa Trofa; Takuya Ohtani; Brian E Nolan; Sarah E Henrickson; Michele P Lambert; Taylor Olmsted Kim; Jenny M Despotovic; Scott Feldman; Olajumoke O Fadugba; Patricia Takach; Melanie Ruffner; Soma Jyonouchi; Jennifer Heimall; Kathleen E Sullivan; E John Wherry; Neil Romberg
Journal:  J Allergy Clin Immunol       Date:  2019-08-22       Impact factor: 10.793

Review 2.  Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.

Authors:  Mélanie Souyris; José E Mejía; Julie Chaumeil; Jean-Charles Guéry
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

3.  Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.

Authors:  Beth C Holbrook; Ralph B D'Agostino; S Tyler Aycock; Matthew J Jorgensen; Mallinath B Hadimani; S Bruce King; Martha A Alexander-Miller
Journal:  Vaccine       Date:  2017-09-28       Impact factor: 3.641

4.  TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.

Authors:  John S S Butterfield; Moanaro Biswas; Jamie L Shirley; Sandeep R P Kumar; Alexandra Sherman; Cox Terhorst; Chen Ling; Roland W Herzog
Journal:  Hum Gene Ther Methods       Date:  2019-06       Impact factor: 2.396

5.  Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling.

Authors:  Natalia V Giltiay; Geraldine L Shu; Anthony Shock; Edward A Clark
Journal:  Arthritis Res Ther       Date:  2017-05-15       Impact factor: 5.156

Review 6.  Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Authors:  Walaa Darwiche; Brigitte Gubler; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

7.  FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice.

Authors:  Bence Szikora; Anita Marx; Péter K Jani; Orsolya Pipek; Viktor Müller; István Csabai; Imre Kacskovics
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

8.  Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1.

Authors:  Tobias Hilbert; Folkert Steinhagen; Christina Weisheit; Georg Baumgarten; Andreas Hoeft; Sven Klaschik
Journal:  Mediators Inflamm       Date:  2015-12-06       Impact factor: 4.711

9.  IL-6 promotes the differentiation of a subset of naive CD8+ T cells into IL-21-producing B helper CD8+ T cells.

Authors:  Rui Yang; April R Masters; Karen A Fortner; Devin P Champagne; Natalia Yanguas-Casás; Daniel J Silberger; Casey T Weaver; Laura Haynes; Mercedes Rincon
Journal:  J Exp Med       Date:  2016-09-26       Impact factor: 14.307

10.  Potential Chronotherapeutic Optimization of Antimalarials in Systemic Lupus Erythematosus: Is Toll-Like Receptor 9 Expression Dependent on the Circadian Cycle in Humans?

Authors:  Erika Aurora Martínez-García; Maria Guadalupe Zavala-Cerna; Andrea Verónica Lujano-Benítez; Pedro Ernesto Sánchez-Hernández; Beatriz Teresita Martín-Márquez; Flavio Sandoval-García; Mónica Vázquez-Del Mercado
Journal:  Front Immunol       Date:  2018-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.